- Home
- ADAG vs SEER Comparison
ADAG vs SEER Comparison
Compare ADAG & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADAG | SEER |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.5M | 98.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ADAG | SEER |
|---|---|---|
| Price | $2.97 | $1.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 211.8K | 128.0K |
| Earning Date | 08-12-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $103,204.00 | ★ $16,376,999.00 |
| Revenue This Year | $4,446.34 | $22.37 |
| Revenue Next Year | N/A | $30.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.11 |
| 52 Week Low | $1.30 | $1.62 |
| 52 Week High | $3.16 | $2.41 |
Technical Indicators
Market Signals| Indicator | ADAG | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 72.46 | 38.73 |
| Support Level | $1.69 | $1.84 |
| Resistance Level | $2.94 | $1.92 |
| Average True Range (ATR) | 0.37 | 0.05 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 83.54 | 0.00 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.